Flare Capital Partners

Flare Capital Partners is a prominent Boston-based venture capital firm exclusively focused on investing in early-stage and emerging healthcare technology and services companies. The firm is dedicated to identifying and nurturing innovative solutions that have the potential to transform the healthcare industry, addressing critical challenges related to cost, quality, and access. Their investment thesis centers on leveraging technology to drive efficiency, improve patient outcomes, and create new models of care delivery.

The firm typically invests in Seed, Series A, and Series B rounds, often taking a lead or co-lead position. Flare Capital is known for its hands-on approach, providing not just capital but also strategic guidance, operational support, and access to an extensive network of industry experts and potential partners. Their initial investment checks generally range from $5 million to $15 million, with significant capital reserved for follow-on investments to support portfolio companies through subsequent growth stages. This strategy allows them to build substantial positions in promising ventures and provide sustained support as companies scale.

Flare Capital Partners has demonstrated consistent growth and strong limited partner confidence, evidenced by their successful fundraises. In 2017, they closed their second fund, Flare Capital Partners II, with $200 million in commitments. Building on this momentum, they successfully raised $255 million for Flare Capital Partners III in 2021. The increasing size of their funds underscores their established reputation and ability to attract significant capital, enabling them to make impactful investments in the rapidly evolving healthcare technology landscape. Their deep domain expertise and focused strategy position them as a key partner for entrepreneurs building the next generation of healthcare solutions.